Abington Neurological Associates

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease10 trials
• Narcolepsy2 trials
• Migraine1 trial
• Multiple sclerosis1 trial
• Obstructive sleep apnoea1 trial

Phase

• Phase 37 trials
• Phase 23 trials
• Phase 1/21 trial
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting5 trials
• Completed3 trials
• Enrolling by invitation2 trials
• Recruiting2 trials
• Terminated2 trials
• Not yet recruiting1 trial

Lead sponsor

• ACADIA Pharmaceuticals Inc.2 trials
• Alzheon Inc.2 trials
• Hoffmann-La Roche2 trials
• Acumen Pharmaceuticals1 trial
• Apnimed1 trial
• and 7 more

Running trials

• Recruiting

  A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  NCT07675135· Phase 3· Harmony Biosciences Management, Inc.· Source

  Contact: Rachel Grossman

• Recruiting

  A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

  NCT07609914· Phase 4· Pfizer· Source

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

• Enrolling by invitation

  ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

  NCT06194799· Phase 3· ACADIA Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

  NCT06335173· Phase 2· Acumen Pharmaceuticals· Source

• Recruiting

  ACP-204 in Adults With Alzheimer's Disease Psychosis

  NCT06159673· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

  Contact: Christine Murphy

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· Phase 2· Cognition Therapeutics· Source

• Active, not recruiting

  A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

  NCT05269004· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

  NCT04639050· Phase 1/2· Hoffmann-La Roche· Source

• Active, not recruiting

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· Phase 3· Eisai Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Migraine1 recruiting
• Narcolepsy1 recruiting
• Obstructive sleep apnoea1 recruiting

Closed trials

• Completed

  Observational Study of LUMRYZ in Narcolepsy

  NCT06792708· Avadel· Source

• Terminated

  Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

  NCT06304883· Phase 3· Alzheon Inc.· Source

• Terminated

  A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

  NCT03919162· Phase 2· Vivoryon Therapeutics N.V.· Source

• Completed

  An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

  NCT04770220· Phase 3· Alzheon Inc.· Source

• Completed

  TRC-PAD Program: In-Clinic Trial-Ready Cohort

  NCT04004767· University of Southern California· Source